Recruiting PHASE3 INTERVENTIONAL 2-arm NCT04814446

Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts (VAC-WARTS)

Efficacy of the Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts

Sponsor: Assistance Publique - Hôpitaux de Paris

Interventions Vaccination

Updated 9 times since 2021 Last updated: Jan 21, 2025 Started: Jun 29, 2022 Primary completion: Jun 29, 2025 Completion: Jun 29, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Palmar or Plantar Warts, this trial is actively recruiting participants. The trial is conducted by Assistance Publique - Hôpitaux de Paris and has accumulated 9 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Feb 2025 — Present [monthly]

Recruiting PHASE3
Sep 2024 — Feb 2025 [monthly]

Recruiting PHASE3
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE3
Feb 2024 — Jul 2024 [monthly]

Recruiting PHASE3
Sep 2022 — Feb 2024 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting

▶ Show 4 earlier versions

Jun 2022 — Sep 2022 [monthly]

Not Yet Recruiting PHASE3
Jan 2022 — Jun 2022 [monthly]

Not Yet Recruiting PHASE3
Sep 2021 — Jan 2022 [monthly]

Not Yet Recruiting PHASE3
Apr 2021 — Sep 2021 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assistance Publique - Hôpitaux de Paris

Data source: Assistance Publique - Hôpitaux de Paris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France